In response to interim findings from a Swedish randomised control trial about AI-supported breast screening published in Lancet Oncology, Dr Kotryna Temcinaite, head of research communications at Breast Cancer Now, said:
“Detecting breast cancer early is crucial as the sooner it’s diagnosed the better the chance of treatment being successful. We look forward to the final results of this exciting Swedish trial to understand if AI can help improve breast cancer screening and increase capacity in the future.
"But there are urgent issues in the breast screening programme in the UK that must be addressed now, including outdated IT systems which take up valuable staff time and delay improvements.
"That’s why Breast Cancer Now has launched a transformation blueprint which sets out the steps the programme in England must take to ensure it’s ready to make the most of new innovations, like AI, in the years to come.”